Johnson Matthey (JMPLY) Given Average Rating of “Buy” by Brokerages
Shares of Johnson Matthey (OTCMKTS:JMPLY) have earned a consensus rating of “Buy” from the six brokerages that are covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation and four have assigned a buy recommendation to the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $94.00.
Several equities research analysts recently issued reports on the stock. ValuEngine raised shares of Johnson Matthey from a “sell” rating to a “hold” rating in a research note on Wednesday, January 2nd. Investec lowered shares of Johnson Matthey from a “hold” rating to a “sell” rating in a research note on Friday, April 12th. Finally, Zacks Investment Research raised shares of Johnson Matthey from a “hold” rating to a “buy” rating and set a $94.00 price objective for the company in a research note on Wednesday, April 3rd.
Shares of OTCMKTS JMPLY traded down $3.38 during midday trading on Friday, hitting $89.02. The stock had a trading volume of 2,998 shares, compared to its average volume of 1,452. Johnson Matthey has a 1 year low of $67.00 and a 1 year high of $102.55. The company has a market cap of $8.61 billion, a PE ratio of 16.13, a price-to-earnings-growth ratio of 1.24 and a beta of 1.49.
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
Recommended Story: How Do You Make Money With Penny Stocks?
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.